申请人:Neurocrine Biosciences, Inc.
公开号:US06537998B1
公开(公告)日:2003-03-25
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:
wherein Ar, A, B, Q, R1, R2, R3a, R3b, R6, R7 and m are as defined herein, including stereoisomers, prodrugs and pharmaceutical acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
GnRH受体拮抗剂被披露出来,对男性和女性的各种与性激素相关的疾病具有治疗作用。本发明的化合物具有以下结构:其中Ar、A、B、Q、R1、R2、R3a、R3b、R6、R7和m的定义如本文所述,包括立体异构体、前药和其药用可接受盐。还披露了含有本发明化合物的组合物,与药用可接受载体结合,以及与其相关的用于拮抗需要者体内促性腺激素释放激素的方法。